|
1
|
Apalla Z, Lallas A, Sotiriou E, Lazaridou
E and Ioannides D: Epidemiological trends in skin cancer. Dermatol
Pract Concept. 7:1–6. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miller AJ and Mihm MC Jr: Melanoma. N Engl
J Med. 355:51–65. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kalal BS, Upadhya D and Pai VR:
Chemotherapy resistance mechanisms in advanced skin cancer. Oncol
Rev. 11:3262017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Deng LP, Dong J, Cai H and Wang W:
Cantharidin as an antitumor agent: A retrospective review. Curr Med
Chem. 20:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shen M, Wu MY, Chen LP, Zhi Q, Gong FR,
Chen K, Li DM, Wu Y, Tao M and Li W: Cantharidin represses invasion
of pancreatic cancer cells through accelerated degradation of MMP2
mRNA. Sci Rep. 5:118362015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zheng LH, Bao YL, Wu Y, Yu CL, Meng X and
Li YX: Cantharidin reverses multidrug resistance of human hepatoma
HepG2/ADM cells via down-regulation of P-glycoprotein expression.
Cancer Lett. 272:102–109. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xie D, Xie J, Wan Y, Ma L, Qi X, Wang K
and Yang S: Norcantharidin blocks Wnt/β-catenin signaling via
promoter demethylation of WIF-1 in glioma. Oncol Rep. 35:2191–2197.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ji BC, Hsiao YP, Tsai CH, Chang SJ, Hsu
SC, Liu HC, Huang YP, Lien JC and Chung JG: Cantharidin impairs
cell migration and invasion of A375.S2 human melanoma cells by
suppressing MMP-2 and −9 through PI3K/NF-κB signaling pathways.
Anticancer Res. 35:729–738. 2015.PubMed/NCBI
|
|
10
|
Hsiao YP, Tsai CH, Wu PP, Hsu SC, Liu HC,
Huang YP, Yang JH and Chung JG: Cantharidin induces G2/M phase
arrest by inhibition of Cdc25c and Cyclin A and triggers apoptosis
through reactive oxygen species and the mitochondria-dependent
pathways of A375.S2 human melanoma cells. Int J Oncol.
45:2393–2402. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wandler A, Riber-Hansen R, Hager H,
Hamilton-Dutoit SJ, Schmidt H, Nielsen BS, Stougaard M and
Steiniche T: Quantification of microRNA-21 and microRNA-125b in
melanoma tissue. Melanoma Res. 27:417–428. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Latchana N, Ganju A, Howard JH and Carson
WE III: MicroRNA dysregulation in melanoma. Surg Oncol. 25:184–189.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li H, Yuan SM, Yang M, Zha H, Li XR, Sun
H, Duan L, Gu Y, Li AF, Weng YG, et al: High intensity focused
ultrasound inhibits melanoma cell migration and metastasis through
attenuating microRNA-21-mediated PTEN suppression. Oncotarget.
7:50450–50460. 2016.PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang X, Lin C, Lu A, Lin G, Chen H, Liu
Q, Yang Z and Zhang H: Liposomes equipped with cell penetrating
peptide BR2 enhances chemotherapeutic effects of cantharidin
against hepatocellular carcinoma. Drug Deliv. 24:986–998. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li W, Xie L, Chen Z, Zhu Y, Sun Y, Miao Y,
Xu Z and Han X: Cantharidin, a potent and selective PP2A inhibitor,
induces an oxidative stress-independent growth inhibition of
pancreatic cancer cells through G2/M cell-cycle arrest and
apoptosis. Cancer Sci. 101:1226–1233. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Garajová I, Ferracin M, Porcellini E,
Palloni A, Abbati F, Biasco G and Brandi G: Non-Coding RNAs as
predictive biomarkers to current treatment in metastatic colorectal
cancer. Int J Mol Sci. 18(pii): E15472017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van Beijnum JR, Giovannetti E, Poel D,
Nowak-Sliwinska P and Griffioen AW: miRNAs: Micro-managers of
anticancer combination therapies. Angiogenesis. 20:269–285. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Deng J, Wang Y, Lei J, Lei W and Xiong JP:
Insights into the involvement of noncoding RNAs in 5-fluorouracil
drug resistance. Tumour Biol. 39:10104283176975532017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mao XH, Chen M, Wang Y, Cui PG, Liu SB and
Xu ZY: MicroRNA-21 regulates the ERK/NF-κB signaling pathway to
affect the proliferation, migration, and apoptosis of human
melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN. Mol
Carcinog. 56:886–894. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Martin del Campo SE, Latchana N, Levine
KM, Grignol VP, Fairchild ET, Jaime-Ramirez AC, Dao TV, Karpa VI,
Carson M, Ganju A, et al: MiR-21 enhances melanoma invasiveness via
inhibition of tissue inhibitor of metalloproteinases 3 expression:
In vivo effects of MiR-21 inhibitor. PLoS One. 10:e01159192015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Wu R, Liu Z, Fan J and Yang H:
Enforced expression of microRNA-21 influences the replication of
varicella-zoster virus by triggering signal transducer and
activator of transcription 3. Exp Ther Med. 7:1291–1296. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fu X, He Y, Wang X, Peng D, Chen X, Li X
and Wang Q: Overexpression of miR-21 in stem cells improves ovarian
structure and function in rats with chemotherapy-induced ovarian
damage by targeting PDCD4 and PTEN to inhibit granulosa cell
apoptosis. Stem Cell Res Ther. 8:1872017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bu LL, Yu GT, Wu L, Mao L, Deng WW, Liu
JF, Kulkarni AB, Zhang WF, Zhang L and Sun ZJ: STAT3 Induces
Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC. J Dent Res.
96:1027–1034. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
George S, Miao D, Demetri GD, Adeegbe D,
Rodig SJ, Shukla S, Lipschitz M, Amin-Mansour A, Raut CP, Carter
SL, et al: Loss of PTEN Is associated with resistance to anti-PD-1
checkpoint blockade therapy in metastatic uterine leiomyosarcoma.
Immunity. 46:197–204. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou K, Zhong Q, Wang YC, Xiong XY, Meng
ZY, Zhao T, Zhu WY, Liao MF, Wu LR, Yang YR, et al: Regulatory T
cells ameliorate intracerebral hemorrhage-induced inflammatory
injury by modulating microglia/macrophage polarization through the
IL-10/GSK3β/PTEN axis. J Cereb Blood Flow Metab. 37:967–979. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mondal S, Ghosh-Roy S, Loison F, Li Y, Jia
Y, Harris C, Williams DA and Luo HR: PTEN negatively regulates
engulfment of apoptotic cells by modulating activation of Rac
GTPase. J Immunol. 187:5783–5794. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Conde-Perez A and Larue L: PTEN and
melanomagenesis. Future Oncol. 8:1109–1120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li WX, Chen X, Yang Y, Huang HM, Li HD,
Huang C, Meng XM and Li J: Hesperitin derivative-11 suppress
hepatic stellate cell activation and proliferation by targeting
PTEN/AKT pathway. Toxicology. 381:75–86. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He Z, Chen AY, Rojanasakul Y, Rankin GO
and Chen YC: Gallic acid, a phenolic compound, exerts
anti-angiogenic effects via the PTEN/AKT/HIF-1α/VEGF signaling
pathway in ovarian cancer cells. Oncol Rep. 35:291–297. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guo YB, Ji TF, Zhou HW and Yu JL: Effects
of microRNA-21 on nerve cell regeneration and neural function
recovery in diabetes mellitus combined with cerebral infarction
rats by targeting PDCD4. Mol Neurobiol. 55:2494–2505. 2018.
View Article : Google Scholar : PubMed/NCBI
|
